ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TGTX TG Therapeutics Inc

16.45
-0.31 (-1.85%)
Jun 14 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
TG Therapeutics Inc TGTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.31 -1.85% 16.45 23:00:02
Open Price Low Price High Price Close Price Previous Close
16.64 16.235 16.97 16.55 16.76
more quote information »

Recent News

Date Time Source Heading
6/10/202410:23EDGAR2Form PX14A6G - Notice of exempt solicitation submitted by..
6/07/202406:50GLOBETG Therapeutics to Participate in the Goldman Sachs 45th..
6/03/202406:30GLOBETG Therapeutics to Participate in the Jefferies Global..
5/31/202406:30GLOBETG Therapeutics Announces Presentations for BRIUMVI®..
5/28/202406:30GLOBETG Therapeutics Announces Schedule of Upcoming Presentations..
5/06/202415:59EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/01/202406:00GLOBETG Therapeutics Provides Business Update and Reports First..
4/30/202415:55GLOBETG Therapeutics to Host Conference Call on First Quarter..
4/18/202406:30GLOBETG Therapeutics Announces Additional Data Presentations for..
4/18/202406:00GLOBETG Therapeutics Awarded National Contract by the Department..
4/15/202406:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI®..
3/08/202406:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
3/01/202406:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI®..
2/29/202416:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/28/202406:24EDGAR2Form 8-K - Current report
2/28/202406:00GLOBETG Therapeutics Provides Business Update and Reports Fourth..
2/27/202406:30GLOBETG Therapeutics Announces Issuance of Additional Patents for..
2/26/202406:00GLOBETG Therapeutics Announces European Launch of BRIUMVI®..
2/23/202406:30GLOBETG Therapeutics to Host Conference Call on Fourth Quarter..
2/20/202406:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
2/14/202420:53EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
2/14/202414:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/26/202415:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/10/202406:37EDGAR2Form 8-K - Current report
1/10/202406:00GLOBETG Therapeutics Provides Preliminary Fourth Quarter and Full..
1/09/202408:20APSBiotech Massively Bid Up Before Opening Bell
1/09/202406:00GLOBETG Therapeutics Announces Global License Agreement with..
1/08/202417:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202417:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/05/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/05/202410:02EDGAR2Form 144 - Report of proposed sale of securities
1/05/202406:30GLOBETG Therapeutics to Participate in the 42nd Annual J.P...
1/03/202415:46EDGAR2Form 144 - Report of proposed sale of securities
11/27/202306:30GLOBETG Therapeutics to Participate in the 6th Annual Evercore..
11/06/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/03/202306:30GLOBETG Therapeutics to Participate in the 5th Annual Guggenheim..
11/01/202306:33EDGAR2Form 8-K - Current report
11/01/202306:30GLOBETG Therapeutics Provides Business Update and Reports Third..
10/30/202306:30GLOBETG Therapeutics to Host Conference Call on Third Quarter..
10/12/202310:00GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI..
10/11/202309:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI..
10/02/202306:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
9/29/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/22/202306:30GLOBETG Therapeutics to Participate in the 2023 Cantor Global..
9/07/202306:30GLOBETG Therapeutics to Participate in the H.C. Wainwright 25th..
8/14/202308:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/04/202315:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/01/202306:29EDGAR2Form 8-K - Current report
8/01/202306:15GLOBETG Therapeutics Provides Business Update and Reports Second..
8/01/202306:00GLOBETG Therapeutics and Neuraxpharm Announce Ex-US..

Your Recent History

Delayed Upgrade Clock